Skip to main content

Convey Computer Adds UK's TGAC to Client List

Premium

Convey Computer said this week that the UK’s Genome Analysis Center, TGAC, has purchased two Convey HC-1ex hybrid-core systems, which will be used for genomic data analysis.

The Convey infrastructure adds to an existing compute cluster at TGAC and a ccNUMA-based high performance computing environment.

Mario Caccamo, TGAC’s deputy director, explained that the center decided to purchase additional hardware to speed up its data analysis.

“We offloaded some of our sequence alignment demand to the Convey hybrid-core systems, because they can handle the alignment algorithms much more efficiently,” he said in a statement.

Specifically, TGAC researchers will use the new infrastructure to handle computationally demanding projects such as resequencing alignment for wheat and other polyploidy species, Convey said.

The financial details of the purchase were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.